Abiopharma

News list

Director ROSE B ANDREW 🟢 acquired 402 shares (1 derivative) of GREIF, INC (GEF, GEF-B) Transaction Date: May 01, 2026 | Filing ID: 000097

Full text

News bot May 1, 2026, 10:16 p.m.
🔍 ROSE B ANDREW (Director)

Company: GREIF, INC (GEF, GEF-B)

Report Date: 2026-05-01
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 1
- Holdings reported: 0
- Total shares acquired: 402
Detailed Transactions and Holdings:
- Acquired 402 shares of Phantom Stock Units (Cash Only Rights) (Derivative)
  Date: 2026-05-01 | Code: A | equity_swap_involved: 0 | shares_owned_after: 3,313.38 | transaction_form_type: 4 | Footnotes: F1, F2, F2, F3
Footnotes:
- F1: Each phantom stock unit is the economic equivalent of one share of Class A Common Stock of Greif, Inc.
- F2: The phantom stock units are to be settled in cash upon the earlier of (i) a future fixed date designated by the Reporting Person made at the time of the deferral election, or (ii) the Reporting Person's termination from the Board due to his retirement, death, disability or other reason.
- F3: Includes 24.10 units received on April 1, 2026 in lieu of payment of dividends on outstanding phantom units. Dividends paid on one phantom unit are equivalent in value to dividends paid on one share of Class A Common Stock.